[1]
S. . Sangalapalle, “Solubility Enhancement Strategies for BCS Class II Drugs in Orally Disintegrating Tablet Platforms: A Review”, J. Drug Delivery Ther., vol. 16, no. 9, pp. 216–222, Sep. 2026, doi: 10.22270/jddt.v16i9.7974.